UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

_________________________________

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

_________________________________

 

 

Date of Report

 

May 21, 2012

(Date of earliest event reported)

 

IVAX Diagnostics, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

(State or other jurisdiction of

incorporation or organization) 

 

1-14798

(Commission File Number)

 

11-3500746

(IRS Employer Identification No.)

       

2140 North Miami Avenue

Miami, Florida

(Address of principal executive offices) 

     

33127

(Zip Code)

 

 

(305) 324-2300

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

¨ Pre-commencement communications pursuant to Rule 13e4(c) under the Exchange Act (17 CFR 240.13e-4(c))

  

 

 

 
 

 

Item 2.02 Results of Operations and Financial Condition.

 

On May 21, 2012, the registrant issued a press release announcing its financial results for the quarter ended March 31, 2012. A copy of the press release is being furnished as Exhibit 99.1 to this Current Report on Form 8-K.

 

The information in this Current Report on Form 8-K (including Exhibit 99.1) is furnished pursuant to Item 2.02 and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibit 99.1 - Press Release dated May 21, 2012.

 

2
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  IVAX DIAGNOSTICS, INC.
   
   
Dated: May 21, 2012 By:  /s/ Arthur R. Levine
   

Arthur R. Levine

Vice President - Finance and
Chief Financial Officer

3
 

 

EXHIBIT INDEX

 

Exhibit Description
   
99.1 Press Release dated May 21, 2012.

 

4

Ivax Diagnostics (AMEX:IVD)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Ivax Diagnostics Charts.
Ivax Diagnostics (AMEX:IVD)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Ivax Diagnostics Charts.